Dendritic Cell-Based In Situ Nanovaccine for Reprogramming Lipid Metabolism to Boost Tumor Immunotherapy

Cancer vaccines have been considered to be an alternative therapeutic strategy for tumor therapy in the past decade. However, the popularity and efficacy of cancer vaccines were hampered by tumor antigen heterogeneity and the impaired function of cross-presentation in the tumor-infiltrating dendriti...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	ACS nano 2023-12, Vol.17 (24), p.24947-24960
Hauptverfasser:	Qin, You-Teng, Liu, Xin-Hua, An, Jia-Xin, Liang, Jun-Long, Li, Chu-Xin, Jin, Xiao-Kang, Ji, Ping, Zhang, Xian-Zheng
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antigens, Neoplasm - metabolism Cancer Vaccines Dendritic Cells Disease Models, Animal Immunotherapy Lipid Metabolism Melanoma - drug therapy Mice Nanoparticles Nanovaccines Neoplasms - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!